Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $48.32M.
ENTERPRISE VALUE (EV)
$48.32M
PMV Pharmaceuticals, Inc.
Market Cap
$85.86M
Enterprise Value (EV)
$48.32M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | $85.86M | $48.32M |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.27M | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | $50.63M |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.85M | $94.51M |
| CareCloud, Inc. (CCLD)vs › | $87.96M | $128.58M |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | $29.16M |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | $77.36M |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | $73.73M |
| electroCore, Inc. (ECOR)vs › | $89.44M | $90.50M |
| LENSAR Inc (LNSR)vs › | $82.29M | $71.10M |
Market Cap
$85.86M
Total Debt
$435000.00
Cash
$37.98M
Enterprise Value
$48.32M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
